Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery

Pharmaceutical Research

Volumn 23, Issue 8, 2006, Pages 1835-1841

  Chung, Hyun Jung ^a   Kim, Hong Kee ^a   Yoon, Jun Jin ^a   Park, Tae Gwan ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Angiogenesis; Growth factor delivery; Heparin; PLGA; Porous microsphere

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HEPARIN; MICROSPHERE; POLOXAMER; POLYGLACTIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONJUGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EMULSION; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

AMINES; ANIMALS; EXCIPIENTS; FIBROBLAST GROWTH FACTOR 2; HEPARIN; LACTIC ACID; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSPHERES; NEOVASCULARIZATION, PHYSIOLOGIC; POLYGLYCOLIC ACID; POLYMERS; POROSITY;

EID: 33746928371     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9039-9     Document Type: Article

References (30)

1. P. Carmeliet. Angiogenesis in health and disease. Nat. Med. 9:653-660 (2003).
2. P. Carmeliet. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:389-395 (2000).
3. J. Li and R. S. Kirsner. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc. Res. Tech. 60:107-114 (2003).
4. T. P. Richardson, M. C. Peters, A. B. Ennett, and D. J. Mooney. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19:1029-1034 (2001).
5. K. Y. Lee, M. C. Peters, K. W. Andersonm, and D. J. Mooney. Controlled growth factor release from synthetic extracellular matrices. Nature 408:998-1000 (2000).
6. H. Lee, R. A. Cusick, F. Browne, T. H. Kim, P. X. Ma, H. Utsunomiya, R. Langer, and J. Vacanti. Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. Transplantation 73:1589-1593 (2002).
7. C. L. Casper, N. Yamaguchi, K. L. Kiick, and J. F. Rabolt. Functionalizing electrospun fibers with biologically relevant macromolecules. Biomacromolecules 6:1998-2007 (2005).
8. J. E. Markkanen, T. T. Rissanen, A. Kivela, and S. Yla-Herttuala. Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart-gene therapy. Cardiovasc. Res. 65:656-664 (2005).
9. Y. Cao, P. Lenden, D. Shima, F. Browne, and J. Folkman. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J. Clin. Invest. 98:2507-2511 (1996).
10. J. L. Cleland, E. T. Duenas, A. Park, A. Daugherty, J. Kahn, and J. Kowalski. Development of poly-(D,L-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J. Control. Release 72:13-24 (2001).
11. P. B. O'Donnell and J. W. McGinity. Preparation of microspheres by the solvent evaporation technique. Adv. Drug Del. Rev. 28:25-42 (1997).
12. H. K. Kim and T. G. Park. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. Biotech. Bioeng. 65:659-667 (1999).
13. M. van de Weert W. E. Hennink and W. Jiskoot. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm. Res. 17:1159-1167 (2000).
14. R. Sasisekharan, S. Ernst, and G. Venkataraman. On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans. Angiogenesis 1:45-54 (1997).
15. X. H. Wang, D. P. Li, W. J. Wang, Q. L. Feng, F. Z. Cui, Y. X. Xu, and X. H. Song. Covalent immobilization of chitosan and heparin on PLGA surface. Int. J. Biol. Macromol. 33:95-100 (2003).
16. A. Perets, Y. Baruch, F. Weisbuch, G. Shoshany, G. Neufeld, and S. Cohen. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J. Biomed. Mater. Res. 65A:489-497 (2003).
17. G. C. M. Steffens, C. Yao, P. Prevel, M. Markowicz, P. Schenck, E. M. Noah, and N. Pallua. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng. 10:1502-1509 (2004).
18. H. K. Kim, H. J. Chung, and T. G. Park. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone. J. Control. Release 112: 167-174 (2006).
19. G. T. Hermanson. Bioconjugate Techniques, Academic, San Diego, CA, 1996.
20. J. J. Yoon, S. H. Song, D. S. Lee, and T. G. Park. Immobilization of cell adhesive RGD peptide onto the surface of highly porous biodegradable polymer scaffolds fabricated by a gas foaming/salt leaching method. Biomaterials 25:5613-5620 (2004).
21. O. Jeon, S. W. Kang, H. W. Lim, J. H. Chung, and B. S. Kim. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials 27:1598-1607 (2006).
22. I. Kang, D. K. Baek, Y. M. Lee, and Y. K. Sung. Synthesis and surface characterization of heparin-immobilized polyurethanes. J. Polym. Sci., Part A: Polym. Chem. 36:2331-2338 (1998).
23. V. D. Nadkarni, A. Pervin, and R. J. Lindhardt. Directional immobilization of heparin onto beaded supports. Anal. Biochem. 222(1):59-67 (1994).
24. T. Magoshi, H. Ziani-Cherif, S. Ohya, Y. Nakayama, and T. Matsuda. Thermosensitive heparin coating: heparin conjugated with poly(N- isopropylacrylamide) at one terminus. Langmuir 18:4862-4872 (2002).
25. P. K. Smith, A. K. Mallia, and G. T. Hermanson. Colorimetric method for the assay of heparin content in immobilized heparin preparations. Anal. Biochem. 109:466-473 (1980).
26. G. Caponetti, J. S. Hrkach, B. Kriwet, M. Poh, N. Lotan, P. Colombo, and R. Langer. Microparticles of novel branched copolymers of lactic acid and amino acids: preparation and characterization. J. Pharm. Sci. 88:136-141 (1999).
27. A. Lamprecht, U. F. Schafer, and C. M. Lehr. Visualization and quantification of polymer distribution in microcapsules by confocal laser scanning microscopy (CLSM). Int. J. Pharm. 196:223-226 (2000).
28. A. Lamprecht, U. F. Schafer, and C. M. Lehr. Characterization of microcapsules by confocal laser scanning microscopy: structure, capsule wall composition and encapsulation rate. Eur. J. Pharm. Biopharm. 49:1-9 (2000).
29. L. D. Thompson, M. W. Patoliano, and B. A. Springer. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry 33:3831-3840 (1994).
30. M. Fugita, M. Ishihara, M. Simizu, K. Obara, T. Ishizuka, Y. Saito, H. Yura, Y. Morimoto, B. Takase, T. Matsui, M. Kikuchi, and T. Maehara. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials 25:699-706 (2004).